Anastrazole PBS-listed for breast cancer after menopause

6 June 2003

Postmenopausal women with advanced breast cancer now have another treatment choice in the management of their disease.

This follows the listing of anastrazole (brand name Arimidex) on the Pharmaceutical Benefits Scheme (PBS) for the treatment of advanced hormone-dependent breast cancer in postmenopausal women.

Anastrozole can also be prescribed as adjuvant therapy (treatment that improves the action of another medication) in women with early breast cancer, however, it is not currently PBS subsidised for primary prevention of breast cancer.

Professor John Boyages, executive director of the New South Wales Breast Cancer Institute, has welcomed the increased availability of anastrazole for this group of women.

'We have seen advances in breast cancer treatments over the years but we are always looking for more effective and better tolerated treatments,' Professor Boyages said.

An analysis of 2 randomised double-blind trials compared the effectiveness and tolerability of anastrazole with that of tamoxifen, the current standard treatment for this type of breast cancer (Cancer 2001; 92: 2247-2258).

'Results from the studies show that anastrazole is at least as effective as tamoxifen in postmenopausal women with advanced breast cancer,' Professor Boyages said.

Both treatments were well tolerated, however, there were fewer serious side effects such as deep vein thrombosis in women treated with anastrazole.

Oestrogen is responsible for stimulating tumour growth in around 75 per cent of the breast cancers diagnosed in postmenopausal women, so-called hormone-dependent breast cancer.

In women with hormone-dependent breast cancer, anastrazole provided greater benefit in delaying the progress of the disease.

Anastrozole reduces the growth of a tumour by blocking the action of aromatase, a chemical found in fatty tissue that drives the production of oestrogen in postmenopausal women.


 
Sponsored links

myDr Newsletter

Get myDr delivered to your inbox Privacy Policy
 
Advertisement
Advertisement
Advertisement

This web site is intended for Australian residents and is not a sbstitute for independent professional advice. Information and interactions contained in ths Web site are for infomation purposes only and are not intended ot be used to diagnose,treat , cure or prevent any disease.Further , the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. MIMS Australia Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incured by use of or relance on the information made available via or throught myDr whether arising from negligence or otherwise.
See Privacy Policy and Disclaimer.